Biotech decks that translate science into conviction.
Life-science investors fund de-risked milestones. We translate mechanism of action, pipeline and clinical strategy into a deck that a specialist will respect and a generalist can follow — without dumbing down the science.




What a great Biotech & Pharma deck gets right.
Biotech & Pharma investors weigh a particular set of signals. We build every slide to speak to them.
Pipeline as a value-inflection map
We present your programs as a sequence of de-risking milestones, each tied to data readouts and the value step-up they unlock.
Mechanism made legible
MoA, target rationale and differentiation are visualized for clarity — rigorous enough for a KOL, clear enough for a generalist LP.
Regulatory path framed as strategy
IND, trial design, endpoints and the FDA route are positioned as a deliberate plan, not a list of hurdles.
Comparable exits and the market
We ground the opportunity in real biopharma comps, addressable patient populations and partnership precedent.
Biotech pitch decks, stage by stage.
What investors expect from a Biotech company changes with every round. Pick yours for the metrics, slide order and objections that matter.
Results that speak for themselves.
We've partnered with founders and teams across industries to help them raise with clarity, confidence, and impact.
Investor-ready materials, across industries and stages.
From pre-seed through Series C and beyond.
From kickoff to final delivery. Expedited timelines available.
Unlimited revisions until you're confident in the room.
Trusted by founders. Backed by results.
They were able to give us insight into a comprehensive and emerging landscape. They provided further resources with case studies and data to make our arguments more compelling; while being timely and communicative. They're an asset to any team moving forward.
[They] were educated in the biopharma space and was able to give us insight into the landscape. They provided further resources/data to make our arguments more compelling. He was timely and communicative. An asset to any team moving forward.
(For our acquisition of Modular Water), they really built the case with deep research. Highly professional. They took the time to work through a number of iterations of the project and maintained outstanding communication. Highly recommend.
Built for Biotech & Pharma founders and their investors.
Life-science and biotech VCs, crossover funds, pharma corporate venture arms, and strategic BD teams evaluating partnership or acquisition.
Pfizer and biopharma teams have relied on our research-backed materials to make complex landscapes investor-legible.
Common questions. Clear answers.
Do you understand clinical and regulatory nuance?
Can you visualize a multi-program pipeline?
Will the science be accurate?
What does a custom engagement cost?
How fast can you turn it around?
Do you use templates?
What if I'm not happy with the result?
Keep exploring.
Raising soon? Don't leave it to chance.
Drop your details and we'll send a free deck audit — then jump on a 15-minute intro call to walk through exactly what to fix before you pitch.
- We reply within 24 hours
- Complete founder confidentiality
Got it — your audit is on the way.
We'll review your details and reply within 24 hours. Want to fast-track it? Grab a 15-minute intro call now.
Book your intro call